N@N

OSI Systems Receives $2.9 Million Contract for Complete Range of Patient Monitoring Solutions

_{//science-technology.news-articles.net/content/2 .. plete-range-of-patient-monitoring-solutions.html}
^{Published in Science and Technology on Wednesday, December 15th 2010 at 5:10 GMT by Market Wire}  

HAWTHORNE, Calif.--([ BUSINESS WIRE ])--[ OSI Systems, Inc. ] (NASDAQ:OSIS), a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced that its Healthcare division, Spacelabs Healthcare, has received a contract valued at $2.9 million from a prominent Louisiana based hospital to provide patient monitoring and telemetry solutions, which are expected to be installed throughout the hospitala™s care units.

"We are proud of the opportunity to provide healthcare solutions utilizing our latest technology for patient monitoring and telemetry data, including our newly released SL 3900 Dual Display Central Station and the Ultraview DM3 Dual Mode Vital Signs monitor."

OSI Systems CEO Deepak Chopra, stated, "We are proud of the opportunity to provide healthcare solutions utilizing our latest technology for patient monitoring and telemetry data, including our newly released SL 3900 Dual Display Central Station and the Ultraview DM3 Dual Mode Vital Signs monitor.a

About OSI Systems, Inc.

OSI Systems, Inc. is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries. We combine more than 30 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end product markets. For more information on OSI Systems Inc. or any of its subsidiary companies, visit [ www.osi-systems.com ]. News Filter: OSIS-G

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the company's expectations, goals or intentions about the future, including, the Company's contracts to deliver a broad range of solutions to customers in the healthcare industry.The actual results may differ materially from those described in or implied by any forward-looking statement.